Katz Known for Tireless Effort in Combatting the Opioid Epidemic in His Community
Maple Grove, MN – October 12, 2021 – Upsher-Smith Laboratories, LLC (Upsher-Smith) is pleased to announce that Ira Katz, RPh, owner of Little ... Read More
Company Partners with Mayne Pharma to Expand Product Access
Maple Grove, Minn. – September 28, 2021 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of three additional strengths of Isotretinoin Capsules. The company now offers ... Read More
Migraine Telemedicine Platform Meets Growing Need for Specialized Care Delivered Virtually
Maple Grove, MN – September 14, 2021 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced its partnership with Cove, a telemedicine company focused entirely on ... Read More
MAPLE GROVE, MN – Aug. 16, 2021 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Carbamazepine Extended-Release Tablets, USP in 100 mg, 200 mg and 400 mg strengths. Upsher-Smith’s product is AB-rated to the branded product, Tegretol® XR ... Read More
Maple Grove, MN – August 3, 2021 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that Cheryl Beal Anderson, VP of Global Regulatory Affairs has been selected as a 2021 Women in Business Honoree by The ... Read More
Maple Grove, MN – June 25, 2021 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Isotretinoin Capsules. Upsher-Smith’s product is AB2-rated to the branded product, Absorica® (isotretinoin) capsules.
The isotretinoin capsule market had U.S. sales ... Read More
First Product to Enter the Market under Partnership Agreement which Includes Development and Distribution of Six Ophthalmic and Otic ANDA Products
Maple Grove, MN and Athens, Greece – May 27, 2021 – Upsher-Smith Laboratories, LLC ... Read More
